Lisa Bright

Directeur/Membre du Conseil chez ASCENDIS PHARMA A/S Fortune : - $ au 31/05/2026

Profil

Lisa Jane Bright is currently Chairman at Metadeq, Inc., Non-Executive Director at Dechra Pharmaceuticals Ltd. since 2019, Independent Director at Ascendis Pharma A since 2017, Director at Immedica Pharma AB, Advisor at DRI Healthcare, Executive Partner at Syncona Partners LLP, and President-International at Intercept Pharma Europe Ltd. since 2016.
Former roles include Chairman at Resolution Therapeutics Ltd., Vice President at Gilead Sciences, Inc., President-International at Intercept Pharmaceuticals, Inc. from 2016 to 2021, VP-Commercial Planning & Operations at GSK Plc from 1989 to 2006, General Manager at Gilead Sciences Ireland UC from 2008 to 2014, General Manager- UK & Ireland at Gilead Sciences Ltd. from 2008 to 2014, and Executive Partner at Syncona Ltd. Education includes undergraduate studies at University College London.

Détentions connues dans des sociétés publiques

Société	Date	Nombre d'actions	Valorisation	Date de valorisation
ASCENDIS PHARMA A/S -.--%	31/12/2025	0 ( -.--% )	- $	31/05/2026

Postes actifs de Lisa Bright

Sociétés	Poste	Début
ASCENDIS PHARMA A/S	Directeur/Membre du Conseil	01/04/2017
DECHRA PHARMACEUTICALS	Directeur/Membre du Conseil	01/02/2019
Intercept Pharma Europe Ltd.	Corporate Officer/Principal	01/07/2016
DRI Healthcare	Consultant / Advisor	-
Syncona Partners LLP	Consultant / Advisor	-
Immedica Pharma AB	Directeur/Membre du Conseil	-

Anciens postes connus de Lisa Bright

Sociétés	Poste	Fin
Resolution Therapeutics Ltd.	Président	03/10/2024
INTERCEPT PHARMACEUTICALS, INC.	Corporate Officer/Principal	01/01/2021
Gilead Sciences Ireland UC	Corporate Officer/Principal	01/11/2014
░░░░░░ ░░░░░░░░ ░░░░	░░░░░░░░░ ░░░░░░░░░░░░░░░░░	░░░░░░░░░░
░░░ ░░░	░░░░░░░░░ ░░░░░░░░░░░░░░░░░	░░░░░░░░░░